Long-Term Use of Nimotuzumab in Combination With Intensity-Modulated Radiotherapy and Chemotherapy in the Treatment of Locoregionally Advanced Nasopharyngeal Carcinoma: Experience...

por Fangzheng, Wang, Chuner, Jiang, Zhiming, Ye, Tongxin, Liu, Fengqin, Yan, Lei, Wang, Bin, Li, Fujun, Hu, Ming, Chen, Weifeng, Qin, Zhenfu, Fu
Publicado 2018

Optimization of the margin expanded from the clinical to the planned target volume during intensity-modulated radiotherapy for nasopharyngeal carcinoma

por Fangzheng, Wang, Quanquan, Sun, Chuner, Jiang, Zhimin, Ye, Shuangyan, Yang, Huanhuan, Yu, Jianfang, Shi, Sakamoto, Masoto, Weifeng, Qin, Zhenfu, Fu, Yangming, Jiang, Yuezhen, Wang
Publicado 2017

Addition of 5-fluorouracil to docetaxel/cisplatin does not improve survival in locoregionally advanced nasopharyngeal carcinoma

por Fangzheng, Wang, Chuner, Jiang, Quanquan, Sun, Zhimin, Ye, Tongxin, Liu, Jiping, Liu, Sakamoto, Masoto, Peng, Wu, Kaiyuan, Shi, Weifeng, Qin, Zhenfu, Fu, Yangming, Jiang
Publicado 2017

Addition of chemotherapy to intensity-modulated radiotherapy does not improve survival in stage II nasopharyngeal carcinoma patients

por Fangzheng, Wang, Chuner, Jiang, Quanquan, Sun, Zhimin, Ye, Tongxin, Liu, Jiping, Liu, Sakamoto, Masoto, Peng, Wu, Kaiyuan, Shi, Weifeng, Qin, Zhenfu, Fu, Yangming, Jiang
Publicado 2018